BioCentury
ARTICLE | Company News

Gene therapy company Rocket finds public path

September 12, 2017 11:26 PM UTC

Ophthalmic play Inotek Pharmaceuticals Corp. (NASDAQ:ITEK) will merge with gene therapy company Rocket Pharmaceuticals Ltd. (New York, N.Y.). The combined company will retain Rocket's name and will be located in New York. The partners expect the deal to close in 1Q18.

Rocket shareholders will own about 81% of the combined company; Inotek shareholders will own the remainder. Inotek will reduce headcount by 60% to seven employees...

BCIQ Company Profiles

Inotek Pharmaceuticals Corp.

BCIQ Target Profiles

Adenosine A1 receptor (ADORA1)